Connors Investor Services Inc Meridian Bioscience Inc Transaction History

Connors Investor Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $1.87 Million - $3.03 Million	-172,043 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$15.51 - $17.61 $10,453 - $11,869	674 Added 0.39%	172,043 $3.03 Million
Q4 2018 Feb 13, 2019	SELL	$14.52 - $19.72 $25,482 - $34,608	-1,755 Reduced 1.01%	171,369 $2.98 Million
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $87,006 - $95,794	-5,859 Reduced 3.27%	173,124 $2.58 Million
Q2 2018 Aug 13, 2018	SELL	$13.8 - $16.8 $112,911 - $137,457	-8,182 Reduced 4.37%	178,983 $2.85 Million
Q1 2018 May 10, 2018	SELL	$13.8 - $16.2 $128,905 - $151,324	-9,341 Reduced 4.75%	187,165 $2.66 Million
Q4 2017 Feb 13, 2018	SELL	$13.55 - $15.8 $72,438 - $84,466	-5,346 Reduced 2.65%	196,506 $2.75 Million
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $2.71 Million - $2.9 Million	201,852	201,852 $2.89 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

Stay updated on Connors Investor Services Inc with notifications on news.